These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8709674)
21. Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register. Xhignesse M; Laplante P; Niyonsenga T; Courteau J; Grant AM Can J Cardiol; 2000 Jul; 16(7):879-85. PubMed ID: 10934306 [TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of lipid-lowering treatment according to lipid level. Pilote L; Ho V; Lavoie F; Coupal L; Zowall H; Grover SA Can J Cardiol; 2005 Jun; 21(8):681-7. PubMed ID: 16003451 [TBL] [Abstract][Full Text] [Related]
23. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?]. Champoux N; Latour J Union Med Can; 1994 Feb; 123(2):91-4. PubMed ID: 8203037 [No Abstract] [Full Text] [Related]
24. Statins and the stroke-cholesterol paradox. Van de Wiel A; Caillard CA Neth J Med; 2002 Mar; 60(1):4-9. PubMed ID: 12074043 [TBL] [Abstract][Full Text] [Related]
25. At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention? Johannesson M Eur Heart J; 2001 Jun; 22(11):919-25. PubMed ID: 11428815 [TBL] [Abstract][Full Text] [Related]
26. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. Ong HT QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501 [TBL] [Abstract][Full Text] [Related]
27. [Cardiovascular prevention of high risk patients by hypolipidemic treatment]. Moulin P; Sérusclat A; Bernard S Rev Prat; 2005 Oct; 55(16):1783-7. PubMed ID: 16363428 [TBL] [Abstract][Full Text] [Related]
30. Drug treatment of hypercholesterolaemia. Determine cardiac risk. Capps N; Hartland A BMJ; 1994 Jan; 308(6920):56-7. PubMed ID: 8298358 [No Abstract] [Full Text] [Related]
31. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study. Carrington M; Stewart S Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of lipid metabolism disorders in the elderly]. Mizera W; Grzeszczak W Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534 [TBL] [Abstract][Full Text] [Related]
33. [The characteristics of the hypolipidemic effect of Mevacor with its permanent multiyear use]. Lipovetskiĭ BM Ter Arkh; 1996; 68(12):72-5. PubMed ID: 9054048 [TBL] [Abstract][Full Text] [Related]
34. [Substantiation of increasing doses of statins in clinical practice]. Susekov AV Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456 [No Abstract] [Full Text] [Related]
35. [Dyslipidemias in the elderly]. Schils E Rev Med Brux; 2001 Sep; 22(4):A338-40. PubMed ID: 11680198 [TBL] [Abstract][Full Text] [Related]
36. [Necessity of hypolipemic treatment in patients with coronary disease]. Fernández-Miranda C; Aranda IL Med Clin (Barc); 1999 Mar; 112(11):438. PubMed ID: 10231779 [No Abstract] [Full Text] [Related]